Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chloroquine phosphate 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroquine phosphate |
Inferred relationship |
Some |
|
Chloroquine phosphate 80mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroquine phosphate |
Inferred relationship |
Some |
|
Chloroquine phosphate 50mg/mL injection 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroquine phosphate |
Inferred relationship |
Some |
|
Chloroquine phosphate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroquine phosphate |
Inferred relationship |
Some |
|
Proguanil hydrochloride 100mg tablet and chloroquine phosphate 250mg tablet pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroquine phosphate |
Inferred relationship |
Some |
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroquine phosphate |
Inferred relationship |
Some |
|
Chloroquine phosphate 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroquine phosphate |
Inferred relationship |
Some |
1 |
Chloroquine phosphate 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chloroquine phosphate |
Inferred relationship |
Some |
1 |
Chloroquine phosphate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroquine phosphate |
Inferred relationship |
Some |
1 |
Chloroquine phosphate 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chloroquine phosphate |
Inferred relationship |
Some |
1 |
Chloroquine phosphate 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chloroquine phosphate |
Inferred relationship |
Some |
1 |
Chloroquine phosphate 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chloroquine phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely chloroquine phosphate 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chloroquine phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely chloroquine phosphate 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chloroquine phosphate |
Inferred relationship |
Some |
1 |
Chloroquine phosphate 160 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chloroquine phosphate |
Inferred relationship |
Some |
1 |
Chloroquine phosphate 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chloroquine phosphate |
Inferred relationship |
Some |
1 |